Microdeletion 3q29 SyndromeGeneticsRare diseaseHealthy volunteers
What this study is
The 3q29 deletion syndrome is caused by a deletion of a small part of human chromosome 3, and the duplication syndrome is caused by a duplication of this same small region. The purpose of this study is to understand the medical and behavioral consequences of these syndromes.
Study details
- Sponsor
- Rutgers, The State University of New Jersey
- Conditions
- Microdeletion 3q29 Syndrome · Microduplication 3q29 Syndrome
- Enrolling
- 800 people
- Starts
- 2013-07
- Est. completion
- 2028-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers AcceptedYou may qualify if
- Diagnosis of 3q29 deletion or 3q29 duplication
- Consent from parents or guardians or an adult with 3q29 deletion or 3q29 duplication that does not require a legal guardian or an adult who is the healthy sibling of an individual with 3q29 deletion or 3q29 duplication or a healthy age-matched control
You can't join if
- Clinically significant medical disease that would prohibit participation in the study procedures
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openInternet-Based
Piscataway, New Jersey, United States
- Jennifer Mulle, MHS, PhD · Contact(848) 445-9866jennifer.mulle@rutgers.edu
- Teresa Irving, MSW · Contacttmi21@cabm.rutgers.edu
Recruiting
Study team
Sponsor
Rutgers, The State University of New Jersey
Study ID Pro2021001976
Principal investigator
Jennifer Mulle, MHS, PhD
Rutgers University
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.